EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer

Shraddha Patkar, Tanvi M Shah, Mufaddal Kazi, Sadhana Kannan, Gurudutt Varty, Vikas Ostwal iD, Anant Ramaswamy, Prabhat Bhargav iD, Prajakta Barve, Mahesh Goel

Journal of Hepato-Biliary-Pancreatic Sciences · 2026-06 · 33 (6) · 454-462

DOI: 10.1002/jhbp.70114 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 07.04.2026. Verfasst von Shraddha Patkar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Tata Memorial Hospital and Homi Bhabha National Institution, Mumbai, India. Hauptthemen laut MEDLINE: Gallbladder Neoplasms, Nomograms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gallbladder cancers (GBCs) are aggressive tumors with limited improvement in outcomes over decades. Accurate prediction of survival is crucial for tailored treatment and improved outcomes.

Objective

To develop a nomogram predicting overall survival (OS) in resectable GBCs.

Methods

A retrospective analysis of 1045 patients of resected gallbladder cancer between January 2010 to December 2022 was done. A predictive nomogram was built and was internally validated.

Results

The nomogram included age, original T stage, original N stage, and lympho‐vascular/perineural invasion, CA 19.9, incidental versus non‐incidental GBC, and grade. The Harrell's concordance index for the nomogram was 0.677. The area under the ROC curves for 1‐, 3‐, and 5‐year OS were 72.12, 72.64, and 71.15 respectively. Patients were stratified into low‐risk and high‐risk groups based on a threshold score of 22.48, with significantly different median OS (not reached vs. 31.4 months, p < 0.001).

Conclusions

The developed nomogram demonstrates good discriminative capacity and risk stratification in patients undergoing surgery for GBC and may be utilized for better selection and application of adjuvant treatment strategies, potentially improving outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallbladder NeoplasmsNomogramsHumansRetrospective StudiesFemaleMaleNeoplasm StagingAgedSurvival RateMiddle AgedPrognosisRisk Assessment

Stichwörter der Autor:innen

adjuvant treatment selectiongallbladder cancer survivalpredictive nomogram

Autor:innen und Institutionen

  • Department of Surgical Oncology, Tata Memorial Hospital and Homi Bhabha National Institution, Mumbai, India.
  • Department of Biostatistics, Advanced Centre for Treatment, Research and Education (ACTREC), Navi Mumbai, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.

ORCID-Profile: Vikas Ostwal, Prabhat Bhargav

Zitieren

APA

Patkar, S., Shah, T. M., Kazi, M., Kannan, S., Varty, G., Ostwal, V., Ramaswamy, A., Bhargav, P., Barve, P., & Goel, M. (2026). Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer. Journal of Hepato-Biliary-Pancreatic Sciences, 33(6), 454-462. https://doi.org/10.1002/jhbp.70114

Vancouver

Patkar S, Shah TM, Kazi M, Kannan S, Varty G, Ostwal V, et al. Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(6):454-462. doi:10.1002/jhbp.70114

BibTeX
@article{Patkar2026,
  author = {Patkar, Shraddha and Shah, Tanvi M and Kazi, Mufaddal and Kannan, Sadhana and Varty, Gurudutt and Ostwal, Vikas and Ramaswamy, Anant and Bhargav, Prabhat and Barve, Prajakta and Goel, Mahesh},
  title = {Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  volume = {33},
  number = {6},
  pages = {454--462},
  doi = {10.1002/jhbp.70114}
}
Kostenlos starten →